McKesson Gross Profit 2010-2024 | MCK

McKesson annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • McKesson gross profit for the quarter ending March 31, 2024 was $3.585B, a 16.93% increase year-over-year.
  • McKesson gross profit for the twelve months ending March 31, 2024 was $12.828B, a 3.8% increase year-over-year.
  • McKesson annual gross profit for 2024 was $12.828B, a 3.8% increase from 2023.
  • McKesson annual gross profit for 2023 was $12.358B, a 5.88% decline from 2022.
  • McKesson annual gross profit for 2022 was $13.13B, a 8.08% increase from 2021.
McKesson Annual Gross Profit
(Millions of US $)
2024 $12,828
2023 $12,358
2022 $13,130
2021 $12,148
2020 $12,023
2019 $11,754
2018 $11,184
2017 $11,271
2016 $11,416
2015 $11,411
2014 $8,352
2013 $6,881
2012 $6,402
2011 $5,970
2010 $5,676
2009 $5,378
McKesson Quarterly Gross Profit
(Millions of US $)
2024-03-31 $3,585
2023-12-31 $3,152
2023-09-30 $3,069
2023-06-30 $3,022
2023-03-31 $3,066
2022-12-31 $3,174
2022-09-30 $3,095
2022-06-30 $3,023
2022-03-31 $3,318
2021-12-31 $3,428
2021-09-30 $3,352
2021-06-30 $3,032
2021-03-31 $3,297
2020-12-31 $3,151
2020-09-30 $3,000
2020-06-30 $2,700
2020-03-31 $3,336
2019-12-31 $3,033
2019-09-30 $2,867
2019-06-30 $2,787
2019-03-31 $3,201
2018-12-31 $2,970
2018-09-30 $2,804
2018-06-30 $2,779
2018-03-31 $3,075
2017-12-31 $2,715
2017-09-30 $2,834
2017-06-30 $2,560
2017-03-31 $2,796
2016-12-31 $2,812
2016-09-30 $2,756
2016-06-30 $2,907
2016-03-31 $2,852
2015-12-31 $2,872
2015-09-30 $2,844
2015-06-30 $2,848
2015-03-31 $2,917
2014-12-31 $2,898
2014-09-30 $2,864
2014-06-30 $2,732
2014-03-31 $2,551
2013-12-31 $1,850
2013-09-30 $2,021
2013-06-30 $1,930
2013-03-31 $1,992
2012-12-31 $1,645
2012-09-30 $1,683
2012-06-30 $1,561
2012-03-31 $1,680
2011-12-31 $1,566
2011-09-30 $1,647
2011-06-30 $1,509
2011-03-31 $1,751
2010-12-31 $1,461
2010-09-30 $1,366
2010-06-30 $1,392
2010-03-31 $1,583
2009-12-31 $1,455
2009-09-30 $1,335
2009-06-30 $1,303
2009-03-31 $1,465
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $77.660B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.266B 19.03
Cardinal Health (CAH) United States $24.588B 14.06
West Pharmaceutical Services (WST) United States $24.481B 43.88
Align Technology (ALGN) United States $18.483B 35.69
Cooper (COO) United States $18.411B 27.15
Labcorp (LH) United States $16.992B 14.63
Henry Schein (HSIC) United States $8.474B 15.07
DENTSPLY SIRONA (XRAY) United States $5.328B 13.80
Merit Medical Systems (MMSI) United States $4.690B 25.70
CONMED (CNMD) United States $2.168B 19.66
Patterson (PDCO) United States $2.047B 9.81
STAAR Surgical (STAA) United States $1.969B 75.62
Atrion (ATRI) United States $0.795B 42.47
Lifevantage (LFVN) United States $0.088B 11.30
Pro-Dex (PDEX) United States $0.066B 33.28
Biolase (BIOL) United States $0.005B 0.00